Continuing Professional Development

Perioperative Bleeding Management


Seminar in Patient Blood Management - Focus on perioperative bleeding management

September 29 - October 03, 2017,   WEILL CORNELL MEDICINE - QATAR

Erik Beckers, MD, PhD

Consultant, Internist-hematologist, Hematology Laboratory of Hemostasis and Transfusion, Department of Internal Medicine, Maastricht University Medical Centre, Netherlands

Erik Beckers, MD, PhD
Erik Beckers studied medicine at the University of Maastricht and graduated with honor in 1988. After his military service at the Royal Dutch Navy he started a first residency in Internal Medicine in 1991.

From 1992 till 1996 his scientific research focused on blood group antigens, more specifically RhD variants, at the Blood Bank in Maastricht and Central Laboratory for Blood Transfusion in Amsterdam (now Sanquin Blood Bank and Sanquin Research). In 1997 he defended his PhD thesis titled: ‘Serological and genomic studies on RhD antigens’ at the University of Amsterdam.

In 2002 he was registered as internist after clinical training in Amsterdam and Rotterdam, followed by registration as transfusion medicine specialist in 2003 (Sanquin Blood Bank Rotterdam). From 2002 till 2007 he worked as transfusion medicine specialist in the diagnostic reference laboratory for red cell serology at Sanquin Rotterdam.

From 2007 till 2009 Dr. Beckers continued his medical training in hematology (Haga Hospital The Hague and Maastricht University Medical Centre). From 2009 he is holding a position as internist-hematologist and consultant for Hemostasis and Transfusion in MUMC Maastricht. Main areas of interests are serological diagnostic problems in blood transfusion and after stem cell transplantations, diagnosis of transfusion reactions, and therapeutic interventions in massive blood loss. His research activities are concentrated around the theme: ‘predictors of bleeding’, in search of improved determinants of bleeding risks in congenital bleeding disorders and in patients with chemotherapy induced thrombocytopenia, establishing novel diagnostic algorithms in bleeding tendencies.